DrugandAlcoholDependence114 (2011) 134–139
ContentslistsavailableatScienceDirect
Drug and Alcohol Dependence
journal homepage: www.elsevier.com/locate/drugalcdep
Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and
opioid use disorders: A nationwide follow-up study of Danish substance
users in treatment
MikkelArendta,b,∗,PovlMunk-Jørgensena,LeoSherb,SigneO.W.Jensena
aUnitforPsychiatricResearch,AalborgPsychiatricHospital,AarhusUniversityHospital,Mølleparkvej10,9100Aalborg,Denmark
bDivisionofMolecularImagingandNeuropathology,DepartmentofPsychiatry,ColumbiaUniversityandNewYorkStatePsychiatricInstitute,1051RiversideDrive,NewYork,NY
10032,USA
a r t i c l e i n f o a b s t r a c t
Articlehistory: Thisisaregister-basedcohortstudyof20,581individualsintreatmentforillicitsubstanceusedisorders
Received11May2010 inDenmarkbetween1996and2006.Allinall,1441deathswererecordedduring111,445person-yearsof
Receivedinrevisedform follow-up.Standardizedmortalityratios(SMRs)associatedwithdifferentprimarysubstancetypeswere
14September2010
calculatedandCox-regressionanalyseswereperformedinordertoestablishhazardratios(HR)associ-
Accepted15September2010
atedwithinjectiondruguseandpsychiatriccomorbidity.SMRsforprimaryusersofspecificsubstances
Available online 25 October 2010
were:cannabis:4.9(95%confidenceinterval(CI):4.2–5.8),cocaine:6.4(CI:3.9–10.0),amphetamine:
6.0(CI:4.2–8.3),heroin:9.1(CI:8.5–9.8),andotheropioids7.7(CI:6.6–8.9).ForMDMA(‘ecstasy’)the
Keywords:
crudemortalityratewas1.7/1000person-years(CI:0.4–7.0)andtheSMRwasnotsignificantlyele-
Drug-relatedmortality
Substancemisuse vated.Injectiondrugusewasassociatedwithsignificantlyincreasedhazardratiosinusersofopioids
Psychopathology andcocaine/amphetamine.Overall,psychiatriccomorbiditywasnotassociatedwithincreasedmortality
Injectiondruguse(IDU) (HR:1.1[CI:0.9–1.2],p=.28),butanassociationwasfoundspecificallyamongcocaine/amphetamine
Standardizedmortalityratio users(HR:3.6[CI:2.1–6.4],p<.001).
© 2010 Elsevier Ireland Ltd. All rights reserved.
1. Introduction Somestudiesonprimarycocaineandamphetamineusersexist
(Bartuetal.,2004;Pavarin,2008;Quanetal.,2007;Ribeiroetal.,
Several studies have shown that, in general, illicit substance 2007;Wahrenetal.,1997)butevidenceisstilllackingconcern-
usedisordersareassociatedwithexcessmortality.However,the ing estimates of overall mortality, gender differences, and risks
amountofscientificevidencevariesconsiderablyfordifferentsub- associatedwithinjectiondruguse.Thisdespitethatanumberof
stanceclassesandriskfactors. postmortemstudieshavedemonstratedthatthesesubstancesare
Almostnopublicationsexistconcerningcannabisormethylene- involvedinmanydrugrelateddeaths(Bernsteinetal.,2007;Coffin
dioxymethamphetamine (MDMA commonly known as ‘ecstasy’) etal.,2003;Darkeetal.,2005;Hickmanetal.,2007;Shahetal.,
usedisorders.Forexample,welocatedonlyonepublicationesti- 2008;Torralbaetal.,1996)andthatthenumbercouldbeincreas-
matingexcessmortalityamongindividualswithprimarycannabis ingintheEuropeancountries(O’Dowd,2008;SchifanoandCorkery,
usedisorders(Wahrenetal.,1997).Thisdespitethatcannabisis 2008;Steentoftetal.,2006).
themostcommonlyusedillegalsubstanceintheworld,andthat Thereisextensiveliteratureonopioidusedisorders(e.g.reviews
ithasbeenassociatedwithahighriskofaccidents(Eksborgand byHulseetal.,1999;Wilcoxetal.,2004).Studieshavedocumented
Rajs, 2008; Laumon et al., 2005; Macdonald et al., 2003). Rogers thatthelevelofexcessmortalityisconsiderable,butwithsubstan-
etal.(2009)reviewedtheevidenceconcerningMDMA,andfound tialdifferencesininvestigationsfromdifferentcountries(Bargagli
thatstudiesonmortalityweremostlycaseseriesorrelyingonpost etal.,2006;Colonetal.,2006;DarkeandRoss,2002;Steentoftet
mortemdata. al.,2006),regionswithincountries(Birdetal.,2003),andhistor-
ical time periods (Degenhardt et al., 2005a; Ghodse et al., 1998;
Hickmanetal.,2007;O’Dowd,2008;Shahetal.,2008;Vlahovet
al.,2008;Wahrenetal.,1997).
Whilemostindividualswithopioiddependencehaveinjected
∗
Correspondingauthorat:UnitforPsychiatricResearch,AalborgPsychiatricHos-
thesubstance,theproportionisloweramongprimaryusersofillicit
pital,AarhusUniversityHospital,Mølleparkvej10,9100Aalborg,Denmark.Tel.:+45
stimulants(Mesquitaetal.,2001;Quanetal.,2007;Ribeiroetal.,
72137227;fax:+4572137235.
E-mailaddress:mikkaren@rm.dk(M.Arendt). 2007;Vlahovetal.,2008).Twostudieshavefoundthatinjecting
0376-8716/$–seefrontmatter© 2010 Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.drugalcdep.2010.09.013
M.Arendtetal./DrugandAlcoholDependence114 (2011) 134–139 135
druguseofopioidsisassociatedwithhighermortality(Gossopet otherparaphernaliasuchasspoonsorfilters.Theterm‘substanceusedisorder’is
al.,1996;Hickmanetal.,2003),whiletwostudiesreportnosuch usedthroughoutthetexteventhoughitisnotclearwhethertheparticipantsfulfilled
association (Joe et al., 1982; Sanchez-Carbonell and Seus, 2000). formaldiagnosticcriteriaaccordingtotheInternationalClassificationofDiseases,
Tenthrevision(ICD-10)(WorldHealthOrganization,1992).However,itisassumed
Onestudyonprimaryusersofillicitstimulants(Hseretal.,2006)
thattheysufferedfromsubstanceusedisorderssincetheysoughttreatmentinorder
and one study on users of either opioids or stimulants (Johnson toceasetheuseofanillicitsubstance.
et al., 2005) have found no association either. However, most of TheDanishPsychiatricCaseRegister(Munk-JørgensenandMortensen,1997)
thecitedstudiesdonotreportonsharingofsyringeswhichcould wasusedtolocatetheclientswhohadreceivedpsychiatrictreatmentbeforethey
enteredsubstanceusetreatment.ItcontainsinformationonalladmissionstoDan-
beanimportantfactortoexploresincehepatitisBandC,aswellas
ishpsychiatrichospitalsanddepartmentssince1970.From1995,informationon
AIDSarethemajorreasonsfordeathamongusersofthesubstances
outpatientvisitstopsychiatricdepartmentswasalsoincluded.Diagnosiscodesfrom
(Degenhardtetal.,2006;Fugelstadetal.,2007). theInternationalClassificationofDiseases,EighthRevision(ICD-8)(WorldHealth
A number of longitudinal studies have investigated variables Organization,1971)wereuseduntil1993whentheICD-10wasintroduced.Inthis
atbaselineamongindividualswithsubstanceusedisordersasso- study,thelargemajority(83.7%)ofregistrationswasbasedonICD-10criteria.Dur-
ingthestudyperiodtherewerenoprivatepsychiatricinpatientorhospitalbased
ciated with mortality at a later point in time (Bartu et al., 2004;
outpatientfacilitiesinDenmarkandtherewasequalaccesstotreatment.Theregis-
Bauer et al., 2008; Colon et al., 2006; Gossop et al., 2002; Joe et terthereforecapturesallpsychiatrictreatmentprovidedbyhospitalsandoutpatient
al., 1982; Johnson et al., 2005; Quan et al., 2007; Ravndal and clinicsinDenmark.Allmain,subsidiary,andadditionaldiagnosescanberetrieved.
Vaglum, 1998; Ribeiro et al., 2007; Sanchez-Carbonell and Seus, Registrationsofpsychiatrictreatmentwereusedasaproxymeasureof‘psychi-
atriccomorbidity’,thetermusedthroughoutthetext,althoughonlyinformation
2000;Vlahovetal.,2008).However,forsomereasontheimpactof
onpsychiatricproblemsrequiringtreatmentisincluded.Apersonwasidentified
comorbidpsychiatricproblemshasreceivedalmostnoattention.
ashavingacomorbidpsychiatricdisorderifanydiagnosishadbeengivenforthe
Thispertainstoallsubstanceclasses.Theexistinginvestigations disorderatanypointoftime,aseitheroutpatientorinpatient,beforetreatmentfor
onlyreportsporadicallyonthisthemeandresultshavebeenmixed asubstanceusedisorder.Eachpersonwasenteredonlyonceintotheanalyseson
(Bartuetal.,2004;Baueretal.,2008;Colonetal.,2006;Gossop psychiatriccomorbidity.Incaseofmorethanoneregistrationforpsychiatrictreat-
ment,themoreseverediagnosiswasdeterminedbasedonthefollowinghierarchy:
et al., 2002; Hser et al., 2006; Ravndal and Vaglum, 1998). This
schizophreniaspectrumdisorder(ICD-10:F20,F21,orF25),affectivedisorder,and
is odd since it is known that substance use disorders are highly personalitydisorder.Becauseofalownumberofregistrations,bipolardisorderwas
associatedwithpsychiatricdisordersthatarepresumablynotsub- notincludedintheanalyses.
stancerelated(e.g.ArendtandMunk-Jørgensen,2004;Conwayet TheDanishCivilRegistrationSystem(Pedersenetal.,2006),establishedin1968,
includesallpersonsaliveandresidinginDenmark.Amongothervariables,itcon-
al.,2006;Regieretal.,1990),thatpsychiatriccomorbidityincreases
tainsinformationonCivilRegistrationSystemnumberandcontinuouslyupdated
theriskofrelapsefollowingtreatmentforsubstanceusedisorders
information on vital status. The Civil Registration System number is used as a
(Arendtetal.,2007;Landheimetal.,2006),andthatthesedisor- personalidentifierinallnationalregistersenablingaccuratelinkagebetweenthe
dersareindependentlyassociatedwithexcessmortality(e.g.Felker registersusedinthestudy.
etal.,1996;Roshanaei-MoghaddamandKaton,2009;Sahaetal., ExpectedmortalityratesfromtheDanishpopulationwereretrievedfroma
publicregisterrunbyStatisticsDenmark(StatisticsDenmark,2009).
2007).
ThestudywasapprovedbytheDanishDataProtectionAgency.
We performed a register-based follow-up study involving
individualsintreatmentforillicitsubstanceusedisordersinDen-
2.3. Dataanalysis
markfrom1996onwards.Thefollowingresearchquestionswere
addressed: Standardizedmortalityratios(SMRs)werecalculatedbydividingtheobserved
numberofdeathsfollowingthefirstdayofthefirstregisteredtreatmentepisode
forsubstanceusedisorderswiththeexpectednumberofdeathsbasedondatafrom
1. What are the standardized mortality ratios (SMRs) associated thebackgroundpopulation.Dataonmortalityinthegeneralpopulationwereavail-
withtreatmentforcannabis,cocaine,amphetamine,MDMA,and ableforone-yearagestrata.Standardizedmortalityratioswerestratifiedforgender
opioidusedisorders? sincemortalityratesdiffersubstantiallybetweenyoungmenandyoungwomenin
thegeneralDanishpopulationandbecausetherewasasubstantiallyhighernumber
2. WhataretheSMRsassociatedwithinjectiondruguseandshar-
ofmalescomparedwithfemalesinthesample.ThetotalSMRs,aswellasSMRscon-
ingofsyringes?
cerninginjectiondruguseandpsychiatriccomorbidity,wereadjustedforgender
3. Arecomorbidpsychiatricdisordersassociatedwithexcessmor- differences.Cox-regressionanalyseswereperformedinordertoestablishhazard
tality? ratiosassociatedwithinjectiondruguseandpsychiatriccomorbidity.Theseanaly-
seswereadjustedforageandgender,andtimeatriskwascalculatedfromthefirst
dayofthefirstregisteredtreatmentepisodeanduntileitherdeathoremigration
2. Methods
(annualratesbetween0.7and0.8%intheperiod1996–2006(StatisticsDenmark,
2009)),or31December2006.Injectiondrugusewastreatedasatimedependent
2.1. Studypopulation
variableandinformationfromthesubstanceabusetreatmentregisterwasusedto
determinewhetherinjectiondrugusedevelopedduringfollow-up.Theassump-
Thesampleincludes20,581personswhoreceivedtreatmentinallspecialized
tionofproportionalhazardswasmetforalltheseanalyses.ForallSMRsandhazard
institutionsforillicitsubstanceusedisordersinDenmarkbetween1January1996
ratios,95%confidenceintervals(CIs)werecalculated.Statastatisticalsoftwarewas
and31December2006.
usedforallanalyses(StataCorp,2007).
2.2. Informationfromregisters
3. Results
Thedatasetconsistsofinformationlinkedtogetherfromdifferentregisters.The
DanishSubstanceAbuseTreatmentRegister(DanishNationalBoardofHealth,2006) Atthetimeoffirsttreatmentcontactforillicitsubstanceusedis-
wasusedtoidentifypersonsintreatmentfordifferentsubstanceusedisorders.The
orders,themeanageamongthe20,581individualswas29years
registerwasestablishedin1996inordertosupervisepatternsofsubstanceuse
andtreatmentofsubstanceusedisorders.Itcontainsinformationonallindividuals (median:28years,25percentile:22years;75percentile:35years),
receivingtreatmentinpublicallyfundedinstitutions.Thereareveryfewprivately 76%weremales,73%weresingle,78%hadnochildren,8%didnot
fundedsubstanceusetreatmentinstitutionsinDenmark,exceptforalcoholusedis- haveapermanentaddress,and71%hadnoeducationbeyondele-
orders.Asthepresentstudyisaboutillicitsubstanceusedisorders,thismeansthat mentaryschool.Only14%werecurrentlyemployedwhereasthe
practicallyallpersonsintreatmentareincluded.Thesubstanceusersareregistered
remainderlivedonsubsidiesfromthestate.
withoneprimarysubstanceused,whileitispossibletoberegisteredwithnumer-
oussecondarydrugs.Ifaprimarysubstancecannotbedetermined(e.g.because Thenumberofpersonslistedwithdifferentprimarysubstances
ofnopreferenceforaparticularsubstance)thepersonisregisteredwith‘nomain usedisevidentfromTable1.Useofillicitsubstances,asidefrom
substance’.Forbothprimaryandadditionalsubstancesinformationonfrequency themainsubstanceused,inthemonthbeforetreatmentstartwas
ofuseinthemonthpriortotreatmentstartisregistered.Atthestartoftreatment,
reportedby33%ofcannabisusers,52%ofcocaine/amphetamine
thesubstanceuserisaskedaboutlifetimeinjectiondruguseandwhethersyringes
havebeensharedatanypointpreviously.Thereisnoinformationonsharingof users,66%ofheroinusers,and59%ofotheropioidusers.
136 M.Arendtetal./DrugandAlcoholDependence114 (2011) 134–139
Table1
Deathsper1000person-yearsandstandardizedmortalityratios(SMRs)among20,581personswithsubstanceusedisorders.
Primarysubstance N Deaths Deathsper1000person-years[95%CI] SMRa[95%CI]
Males Females Total Males Females Total
Cannabis 6445 142 5.7[4.8–6.8] 4.0[2.6–6.1] 5.3[4.5–6.3] 4.8[4.0–5.7] 5.9[3.9–9.1] 4.9[4.2–5.8]
Cocaine 838 18 6.6[3.8–11.4] 8.2[3.4–19.8] 7.0[4.4–11.1] 5.2[3.0–9.0] 16.3[6.8–39.2] 6.4[3.9–10.0]
Amphetamine 1553 33 6.6[4.6–9.6] 2.7[1.1–6.4] 5.4[3.8–7.6] 6.0[4.2–8.7] 5.8[2.4–13.9] 6.0[4.2–8.3]
Ecstasy 295 2 1.4[0.2–10.3] 2.2[0.3–15.7] 1.7[0.4–7.0] 1.7[0.2–12.3] 6.7[0.9–47.2] 2.7[0.5–9.1]
Heroin 6666 778 18.0[16.7–19.5] 13.2[11.2–15.6] 16.9[15.8–18.2] 8.7[8.0–9.4] 12.2[10.3–14.4] 9.1[8.5–9.8]
Otheropioidsb 1330 164 23.1[19.2–27.9] 19.7[15.0–25.8] 21.9[18.8–25.5] 7.3[6.1–8.8] 8.7[6.6–11.3] 7.7[6.6–8.9]
Nomainsubstance 3454 304 15.9[14.0–18.0] 9.5[7.4–12.3] 14.1[12.6–15.7] 7.7[6.8–8.8] 7.0[5.4–9.1] 7.6[6.8–8.5]
Total 20,581 1441 13.8[13.0–14.6] 10.3[9.2–11.5] 12.9[12.3–13.6] 7.5[7.1–8.0] 9.2[8.2–10.3] 7.8[7.4–8.2]
a StandardizedwithrespecttoagedistributionintheDanishpopulationformalesandfemalesseparately(e.g.SMRsformaleusersreflectmortalitycomparedwithmales
ofcomparableageinthebackgroundpopulation).
b Otheropioidsincludesillegallyacquiredopioidssuchasmorphine,methadone,andbuprenorphine.
3.1. Overallmortality latedwithnoinjectiondruguseasreference.Foropioiduserswith
lifetimeinjectiondrugusewhohadnotsharedsyringesthehazard
The mean follow-up time was 5.4 years (median: 5.0, 25 ratiowas1.3(95%CI:1.0–1.7,p=.02),whilethehazardratioamong
percentile: 2.5, 75 percentile: 8.4) and the total number of thosewhohadsharedsyringeswas1.5(95%CI:1.2–1.8,p=.002).
person-yearsequaled111,445.Duringfollow-up1441deathswere For cocaine/amphetamine the corresponding hazard ratios were
registered.Table1displaysthenumberofdeathsper1000person- 2.5(95%CI:1.0–6.1,p=.04)and6.8(95%CI:2.8–16.4,p<.001).
years at risk as well as the overall and gender stratified SMRs.
Mortality rates were significantly elevated for all substances, 3.3. Psychiatriccomorbidity
except MDMA, for both genders compared with the background
population. Gender comparisons revealed that the number of Table2includesSMRsfordifferenttypesofpsychiatriccomor-
deaths per 1000 person-years at risk was highest for males and bidityinvarioussubstanceusedisordersstandardizedwithrespect
specifically for male heroin users, while gender stratified SMRs to age and gender. Bipolar disorder is not included in the table
werehighestforfemalesandspecificallyforfemaleheroinusers. becauseoffewdeathsamongsubjectswiththiscomorbidity.Over-
all,thetableshowsthatpsychiatriccomorbiditywasnotassociated
with elevated SMRs. However, in primary cocaine/amphetamine
3.2. Injectiondruguse
users any comorbid psychiatric disorder resulted in an adjusted
hazard ratio of 3.6 (95% CI: 2.1–6.4, p<.001) compared with no
The consequences of lifetime injection drug use were fur-
comorbid psychiatric disorder. No significant associations were
therevaluated.Separateanalysesweremadeforopioids(heroin
observed in primary cannabis, heroin and other opioid users, or
or ‘other opioids’), and cocaine/amphetamine collapsed into one
inthosewithnomainsubstanceused.
group.Intotal,25.7%ofcocaine/amphetamineusersand68.3%of
opioid users reported lifetime injection drug use. Among injec-
4. Discussion
tors, opioid users were more likely to have shared syringes at
somepointcomparedwithcocaine/amphetamineusers(49.8%vs.
23.2%, (cid:2)2=124.5, p<.001). For opioid users the SMR associated Inthissectionwewillsummarizeanddiscussthemainresults
with no injection drug use was 6.3 (95% CI: 5.2–7.6), those who withanemphasisonthefindingswiththeleastamountofevidence
hadinjectedwithoutsharingsyringes9.5(95%CI:8.3–10.9),and frompreviouslypublishedinvestigations.
for those who had shared syringes 10.3 (95% CI: 9.1–11.6). For
cocaine/amphetaminethecorrespondingSMRswere:neverinjec- 4.1. Mortalityfordifferentsubstances
tion drug use: 2.5 (95% CI: 1.2–4.6), injected but never shared
syringes:6.1(95%CI3.2–10.6),andsharedsyringes:15.6(95%CI: A primary cannabis use disorder was associated with a five-
8.9–25.5).Hazardratios,adjustedforageandgender,werecalcu- foldincreaseinmortality.AlthoughthisisaslightlysmallerSMR
Table2
Deathsper1000person-years,standardizedmortalityratios(SMRs)andhazardratios(HR)accordingtopsychiatriccomorbidity.
Deathsper1000person-years/SMRa[95%confidenceinterval(CI)] HRb[95%CI]
Nocomorbid Comorbid Comorbidaffective Comorbid Anycomorbid ‘No’vs.‘Any’
psychiatricdisorder schizophrenia- disorderc personality psychiatric comorbid
spectrum disorder disorderd psychiatric
disorder disorder
Cannabis 5.5/4.7[4.0–5.7] 2.4/1.8[0.5–7.2] 3.4/2.4[1.0–5.8] 5.8/4.3[2.5–7.2] 4.5/3.2[2.1–5.0] 0.7[0.4–1.1],p=.15
Cocaine/amphetamine 4.0/3.6[2.5–5.2] 11.0/9.5[3.1–29.6] 13.1/10.2 18.9/16.3 15.8/13.1 3.6[2.1–6.4],
[4.3–24.5] [9.6–27.5] [8.6–20.0] p<.001
Heroin 16.3/8.1[7.5–8.8] 20.5/11.3[7.5–17.0] 12.4/6.0[3.7–9.6] 24.4/10.1 21.0/9.3[7.8–11.1] 1.2[1.0–1.5],p=.06
[8.1–12.6]
Otheropioids 21.0/6.5[5.5–7.7] 31.4/10.6[4.0–28.3] 13.5/3.4[1.1–10.7] 29.2/7.7[5.2–11.3] 26.6/7.1[5.0–9.9] 1.2[0.8–1.7],p=.44
Nomainsubst. 14.2/7.0[6.2–7.9] 12.1/6.6[3.1–13.8] 14.7/5.7[3.0–11.0] 13.1/4.8[3.3–7.0] 13.2/5.2[3.8–7.0] 0.9[0.6–1.2],p=.47
Total 12.8/7.0[6.6–7.4] 13.3/7.9[5.7–10.8] 9.6/4.9[3.6–6.7] 17.2/7.6[6.5–8.8] 14.6/7.0[6.1–7.9] 1.1[0.9–1.2],p=.28
a Standardizedwithrespecttoageandgender.
b Adjustedforageandgender.
c Excludingbipolardisorder.
d Excludingallsubstanceusedisorders(ICD-10:F10.x–F19.x).
M.Arendtetal./DrugandAlcoholDependence114 (2011) 134–139 137
than what was found for cocaine/amphetamine or opioids it is notsignificantlyelevatedcomparedwiththebackgroundpopula-
noteworthy.OnlyonepreviousstudyhasreportedSMRsforpri- tion, possibly due to lack of statistical power resulting from few
marycannabisusers.Wahrenetal.(1997)foundestimatesof8.0 deathsinthisgroup.Whileanumberofpostmortemstudiesexist,
and 7.4 in two Swedish cohorts from 1971 to 1972 and 1981 to we located no previous studies reporting comparable mortality
1982.However,theSwedishstudyinvolvedjust16deathsamong ratesinprimaryMDMAusers.
cannabisusersanditconcernedonlyuserswhohadbeenhospi- The overall estimates of excess mortality in primary opioid
talizedforpsychiatricdisordersorsomaticillnesses.Otherstudies usersarecomparabletomostpreviouslypublishedinvestigations
havereportedondeathsassociatedwithcannabisuseratherthan (Bargaglietal.,2006;Colonetal.,2006;Davolietal.,2007;Hickman
cannabis use disorders. Sidney et al. (1997) found that cannabis etal.,2003;Oppenheimeretal.,1994;Peruccietal.,1991;Quaglio
usewasassociatedwithincreasedriskofAIDS-relatedmortality etal.,2001;Quanetal.,2007;Sanchez-CarbonellandSeus,2000;
inmen,butfailedtodemonstrateothereffects,andthestudywas Vlahovetal.,2004).Ameta-analysisbyHulseetal.(1999)reported
aboutratherinfrequentusers(‘highuse’definedaslifetimeuseon apooledSMRestimateof13.2(95%CI:12.3–14.1)whichissignifi-
morethansixoccasions).AndreassonandAllebeck(1990)founda cantlyhigherbutclosetoourfindings.
relativeriskofdeathamonghighconsumersofcannabis(useon
more than 50 occasions) of 2.8, but the association disappeared 4.2. Injectiondruguse
followingadjustmentforsocialbackgroundvariables.
Although some case evidence about cannabis and cardiovas- Mortalitywassignificantlyincreasedamonglifetimeinjection
cular fatalities has been published (Bachs and Morland, 2001; drug users. Some studies have reported similar results (Gossop
Mukamal et al., 2008) deaths resulting from overdose due to etal.,1996;Quanetal.,2007;Ribeiroetal.,2007),butthefind-
cannabisaloneareveryunlikely.Insteadtheincreasedmortality ingsareincontrasttootherresearchpapersonbothopioidand
foundinthepresentstudycouldbetheresultofahigherpropen- cocaine/amphetamineuserswherenoassociationbetweeninjec-
sitytoroadaccidents(EksborgandRajs,2008;Macdonaldetal., tiondruguseandmortalityhasbeendemonstrated(Colonetal.,
2003),intentional/violentinjuriesorhomicides(DarkeandDuflou, 2006;Gossopetal.,2002;Hickmanetal.,2003;Hseretal.,2006;
2008;Macdonaldetal.,2003),andvariousothertypesofaccidents Joeetal.,1982;Johnsonetal.,2005;Sanchez-CarbonellandSeus,
orinjuriesassociatedwithcannabisuse. 2000).Onestudyhasinquiredaboutsharingofsyringesbutfound
Another possibility is that secondary use of other substances noassociationwithincreasedmortality(Gossopetal.,2002).Other
explainssomeoftheexcessmortality.Thirty-threepercentofthe studies suggest that injection drug use could be associated with
primary cannabis users had a history of comorbid use of either increasedmortality,forexamplebyshowingahighriskofoverdose
illicit stimulants or opioids in the month before entering treat- relatedtothismodeofadministration(Swiftetal.,1999;Sherman
ment.Similarly,whilecannabisisunlikelytobethesolesubstance et al., 2007) and a very high rate of injection drug use prior to
usedincasesoffataloverdose,thesubstanceisoftenfoundalong substance-relatedfatalities(Darkeetal.,2000,2005).Ingeneral,
withotherdrugsinsuchcases(DarkeandDuflou,2008;Gueyeet however,thereislimiteddirectevidencefromprospectivestudies
al.,2002;Shieldsetal.,2007).Forexample,apostmortemstudy of risks associated with injection drug use in relation to mortal-
fromtheNordiccountriesreportedthatcannabiswasdetectedin ity, especially among primary cocaine/amphetamine users. This
between one-fourth and one-third of the cases (Steentoft et al., emphasizes the importance of the association with excess mor-
2006). talityobservedinthepresentstudy.Theresultsshowthatthisis
It was found that primary users of both cocaine and animportantissuetoaddressintreatmentandpreventionaswell
amphetamine have approximately six times higher death rates asinstudiesonpredictorsofmortalityinsubstanceusepopula-
compared with individuals from the general population of same tions.
age.Thereiscomparablylessknowledgeabouttheexcessmortality
amongpersonsintreatmentforillicitstimulantusedisorders.Most 4.3. Psychiatriccomorbidity
publicationsinvolvefewindividualsorreportonpoly-drugusers
without specific estimates for illicit stimulants. Pavarin (2008) The presence of comorbid psychiatric disorder was not
found a SMR of 4.8 among Italian male cocaine users, while no associated with increased SMRs except for primary users of
fatalities were observed among females. This estimate is similar cocaine/amphetamine.Thesefindingsarenoteworthy,sincethere
tothefindingofthecurrentstudy.Wahrenetal.(1997)reported arealmostnopublicationsonthesignificanceofpsychiatriccomor-
SMRsof9.6and10.0amongprimarystimulantusers,andRibeiro bidityinrelationtoexcessmortalityamongillicitsubstanceusers.
etal.(2007)foundanSMRof7.6inasampleofBrazilianusersof Theoveralllackofsignificanceofpsychiatriccomorbidityiscon-
crackcocaine.However,bothstudiesdealwithsubjectswhohad sistent with findings from two other studies (Bauer et al., 2008;
beenhospitalizedandtheresultsmightthereforenotgeneralizeto Colon et al., 2006). Some associations have been published but
outpatientsubstanceusetreatment,whichisthemostcommonfor the strength is generally limited and the existing studies typi-
thesedisorders(Knappetal.,2007).AstudyfromThailandreported callyassessonlyonespecifictypeofsymptoms(Bartuetal.,2004;
aSMRof4.4amongnon-injectingdrugusersofwhom56.4%used Gossop et al., 2002; Johnson et al., 2005; Ravndal and Vaglum,
amphetamines,andacrudemortalityrateof24.1pr.1000person- 1998). Also, no data exist for many substances. While there is
yearsamongnon-injectingamphetamineusers(Quanetal.,2007). limitedliteraturefromsubstanceusetreatmentstudies,thereare
Previousstudieshavedocumentedthattheexcessmortalityamong severalstudiesoncomorbidsubstanceuseamongindividualswith
illicitstimulantusersislikelytoresultfromseveralcontributing primarypsychiatricdisorders.Generally,excessmortalityhasbeen
factorssuchasoverdose,cardiovasculardisorders,HIV/AIDSand reportedintheseinvestigations(e.g.Rosenetal.,2008;Zivinetal.,
other physical conditions, injuries, homicide/violent deaths, and 2007).
suicide (Degenhardt et al., 2005a; Joe et al., 1982; Macdonald et The finding that cocaine/amphetamine users with psychiatric
al.,2003;Mesquitaetal.,2001;Pavarin,2008;Ribeiroetal.,2007; comorbidityhaveahazardratioof3.6,comparedtothosewith-
Westoveretal.,2007). out, is interesting. This result indicates that either use of these
PrimaryuseofMDMAwasrelativelyrare,whichisinaccordance substances is especially harmful for individuals with psychiatric
withotherstudies(Degenhardtetal.,2005b;Rogersetal.,2009; disorders,orthatuseofstimulantscouldleadtopsychiatricdisor-
Schifano,2004).PrimaryMDMAusewasassociatedwithacrude dersresultinginexcessmortality.Itcouldalsobeachancefinding
all-causemortalityratioof1.7/1000person-years.TheSMRswere due to the relatively large number of statistical tests. The exact
138 M.Arendtetal./DrugandAlcoholDependence114 (2011) 134–139
natureoftheassociationshouldbefurtherinvestigatedinfuture explored.Specifically,theconsequencesofinjectiondruguseand
studies. sharingofsyringesinstimulantusersshouldbeinvestigated.Most
of the findings concerning psychiatric comorbidity in relation to
4.4. Limitations mortalitywerenegative.Thereisapaucityofstudiesoncomorbid
psychiatricdisordersinillicitsubstanceusersandthesesurprising
Thestudyisabouttreatmentseekers,andthiscouldresultin findingsneedfurtherattention.
higherestimatesofexcessmortalitythanwouldbefoundamong
individualswithsubstanceusedisordersinthegeneralpopulation.
References
Conversely, the estimates could be attenuated due to protective
effectsoftreatment.Cautionisthereforewarrantedinextrapolat-
Andreasson,S.,Allebeck,P.,1990.Cannabisandmortalityamongyoungmen:a
ingresultsoutsidetreatmentcontexts.Ontheotherhand,itisvery longitudinalstudyofSwedishconscripts.Scand.J.Soc.Med.18,9–15.
importanttoknowtheSMRsforindividualsintreatment,because Arendt,M.,Munk-Jørgensen,P.,2004.Heavycannabisusersseekingtreatment-
specificriskfactorscanbeaddresseddirectlyinsuchsettings,e.g. prevalenceofpsychiatricdisorders.Soc.Psychiatry.PsychiatryEpidemiol.39,
97–105.
injectiondruguse,thesharingofsyringes,andpsychiatriccomor-
Arendt, M., Rosenberg, R., Foldager, L., Perto, G., Munk-Jørgensen, P., 2007.
bidity. Psychopathology among cannabis-dependent treatment seekers and asso-
As noted above the SMRs concerning opioids and stimulants ciation with later substance abuse treatment. J. Subst. Abuse Treat. 32,
113–119.
are consistent with studies from other countries. This indicates
Bachs,L.,Morland,H.,2001.Acutecardiovascularfatalitiesfollowingcannabisuse.
thatfindingsonmortalityassociatedwithcannabisuse,stimulant ForensicSci.Int.124,200–203.
use,injectiondruguseandpsychiatriccomorbiditycouldgeneral- Bargagli,A.M.,Hickman,M.,Davoli,M.,Perucci,C.A.,Schifano,P.,Buster,M.,Brugal,
T.,Vicente,J.,TheCOSMOEuropeanGroup,2006.Drug-relatedmortalityandits
izetootherculturalsettings.Conversely,demographicvariationas
impactonadultmortalityineightEuropeancountries.Eur.J.PublicHealth16,
wellasdifferencesinpublicsupportsystemsshouldbetakeninto 198–202.
account. Bartu,A.,Freeman,N.C.,Gawthorne,G.S.,Codde,J.P.,Holman,C.D.,2004.Mortalityin
acohortofopiateandamphetamineusersinPerth,WesternAustralia.Addiction
Another limitation is the lack of control for other poten-
99,53–60.
tial variables associated with both substance dependence and Bauer,S.M.,Loipl,R.,Jagsch,R.,Gruber,D.,Risser,D.,Thau,K.,Fischer,G.,2008.
excessmortality(e.g.unhealthylifestyle,riskseekingbehavior,low Mortalityinopioid-maintainedpatientsafterreleasefromanaddictionclinic.
socioeconomic status). It is probable that some of the increased Eur.Addict.Res.14,82–91.
Bernstein, K.T., Bucciarelli, A., Piper, T.M., Gross, C., Tardiff, K., Galea, S., 2007.
deathriskresultsfromthesefactorsratherthansubstanceuseper Cocaine-andopiate-relatedfataloverdoseinNewYorkCity,1990–2000.BMC
se. PublicHealth7,31.
Theextentofsecondarysubstanceusewashighandtheresults Bird,S.M.,Hutchinson,S.J.,Goldberg,D.J.,2003.Drug-relateddeathsbyregion,sex,
andagegroupper100injectingdrugusersinScotland,2000–01.Lancet362,
onmortalityassociatedwithprimarysubstancesshouldbeinter-
941–944.
preted with caution. Also, development of new, and potentially Coffin,P.O.,Galea,S.,Ahern,J.,Leon,A.C.,Vlahov,D.,Tardiff,K.,2003.Opiates,cocaine
moreharmful,substanceuseoverthefollow-upperiodislikely.For andalcoholcombinationsinaccidentaldrugoverdosedeathsinNewYorkCity,
1990–98.Addiction98,739–747.
example,usingthesameregistersasinthepresentstudywehave
Colon,H.M.,Deren,S.,Robles,R.R.,Kang,S.Y.,Cabassa,M.,Sahai,H.,2006.Acompar-
previouslyreportedthat10.4%intreatmentforcannabisusedisor- ativestudyofmortalityamongPuertoRicaninjectiondrugusersinEastHarlem,
dersreceivedtreatmentforprimaryopioidusedisordersatalater NewYork,andBayamon,PuertoRico.J.UrbanHealth83,1114–1126.
Conway,K.P.,Compton,W.,Stinson,F.S.,Grant,B.F.,2006.Lifetimecomorbidityof
pointoftime(Arendtetal.,2007).Thus,theexcessmortalityamong
DSM-IVmoodandanxietydisordersandspecificdrugusedisorders:results
primarycannabisuserscouldresultfromopioiddependencedevel- fromtheNationalEpidemiologicSurveyonAlcoholandRelatedConditions.J.
oping over the follow-up period. On the other hand, it could be Clin.Psychiatry67,247–257.
DanishNationalBoardofHealth,2006.Fællesindholdforregistreringafstofmis-
arguedthatuseofmorethanoneillicitsubstancereflectsthereal-
brugereibehandling(ContentsoftheRegistrationofIndividualsinTreatment
ityofsubstanceusedisorders.Consistentwiththis,postmortem forSubstanceUseDisorders).DanishNationalBoardofHealth,Copenhagen.
studies have detected more than one substance in the majority Darke,S.,Ross,J.,Zador,D.,Sunjic,S.,2000.Heroin-relateddeathsinNewSouth
ofindividualswhodiefromsubstanceusedisorders(Coffinetal., Wales,Australia,1992–1996.DrugAlcoholDepend.60,141–150.
Darke,S.,Ross,J.,2002.Suicideamongheroinusers:rates,riskfactorsandmethods.
2003;Gueyeetal.,2002;Hickmanetal.,2007;Shahetal.,2008; Addiction97,1383–1394.
Shieldsetal.,2007). Darke,S.,Kaye,S.,Duflou,J.,2005.Cocaine-relatedfatalitiesinNewSouthWales,
Itislikelythatthelackofspecificeffectsfrompsychiatriccomor- Australia1993–2002.DrugAlcoholDepend.77,107–114.
Darke, S., Duflou, J., 2008. Toxicology and circumstances of death of homi-
biditycanbeattributedtoasmallnumberofdeathsforspecific
cide victims in New South Wales, Australia 1996–2005. J. Forensic Sci. 53,
substancesandsufferersofspecificdisorders,asevidencedbythe 447–451.
wideconfidenceintervalsinsomeofthecellsinTable2.Thispoten- Davoli,M.,Bargagli,A.M.,Perucci,C.A.,Schifano,P.,Belleudi,V.,Hickman,M.,Salam-
ina,G.,Diecidue,R.,Vigna-Taglianti,F.,Faggiano,F.,2007.Riskoffataloverdose
tiallackofstatisticalpowerisalimitationoftheseresults.Also,
duringandafterspecialistdrugtreatment:theVEdeTTEstudy,anationalmulti-
theanalysesarebasedonindividualswhohadreceivedpsychiatric siteprospectivecohortstudy.Addiction102,1954–1959.
treatmentandcautioniswarrantedingeneralizingtothegeneral Degenhardt, L., Roxburgh, A., Barker, B., 2005a. Underlying causes of cocaine,
amphetamineandopioidrelateddeathsinAustralia.J.Clin.ForensicMed.12,
population.
187–195.
A relatively high number of statistical tests were performed Degenhardt,L.,Copeland,J.,Dillon,P.,2005b.Recenttrendsintheuseof“clubdrugs”:
resulting in risk of type-I error. We chose not to adjust for this, anAustralianreview.Subst.UseMisuse40,1241–1256.
Degenhardt,L.,Hall,W.,Warner-Smith,M.,2006.Usingcohortstudiestoestimate
andthisshouldbetakenintoaccountintheinterpretationofthe
mortalityamonginjectingdrugusersthatisnotattributabletoAIDS.SexTransm.
results. Infect.82,iii56–iii63.
Eksborg,S.,Rajs,J.,2008.Causesandmannersofdeathamongusersofheroin,
4.5. Implications methadone,amphetamine,andcannabisinrelationtopostmortemchemical
testsforillegaldrugs.Subst.UseMisuse43,1326–1339.
Felker,B.,Yazel,J.J.,Short,D.,1996.Mortalityandmedicalcomorbidityamongpsy-
Thehighlevelofexcessmortalityamongcannabisandstimu- chiatricpatients:areview.PsychiatryServ.47,1356–1363.
lantusersisimportant.Thereasonsbehindthefindingsshouldbe Fugelstad,A.,Stenbacka,M.,Leifman,A.,Nylander,M.,Thiblin,I.,2007.Methadone
maintenancetreatment:thebalancebetweenlife-savingtreatmentandfatal
thefocusoffutureinvestigations.Inlightofthewidespreaduseof
poisonings.Addiction102,406–412.
cannabisandstimulants,itisimportanttodeterminewhetheruse Ghodse,H.,Oyefeso,A.,Kilpatrick,B.,1998.MortalityofdrugaddictsintheUnited
ofthesubstancesinitselfisthecauseorwhetheritisexplained Kingdom1967–1993.Int.J.Epidemiol.27,473–478.
Gossop,M.,Griffiths,P.,Powis,B.,Williamson,S.,Strang,J.,1996.Frequencyofnon-
by other factors (e.g. increased risk of other drug use, socioeco-
fatalheroinoverdose:surveyofheroinusersrecruitedinnon-clinicalsettings.
nomicvariables).Similarly,thecausesofdeathshouldbefurther BMJ313,402.
M.Arendtetal./DrugandAlcoholDependence114 (2011) 134–139 139
Gossop,M.,Stewart,D.,Treacy,S.,Marsden,J.,2002.Aprospectivestudyofmortality Ribeiro,M.,Dunn,J.,Sesso,R.,Lima,M.S.,Laranjeira,R.,2007.Crackcocaine:afive-
amongdrugmisusersduringa4-yearperiodafterseekingtreatment.Addiction yearfollow-upstudyoftreatedpatients.Eur.Addict.Res.13,11–19.
97,39–47. Rogers, G., Elston, J., Garside, R., Roome, C., Taylor, R., Younger, P., Zawada, A.,
Gueye,P.N.,Megarbane,B.,Borron,S.W.,Adnet,F.,Galliot-Guilley,M.,Ricordel,I., Somerville,M.,2009.Theharmfulhealtheffectsofrecreationalecstasy:asys-
Tourneau,J.,Goldgran-Toledano,D.,Baud,F.J.,2002.Trendsinopiateandopioid tematicreviewofobservationalevidence.HealthTechnol.Assess.,13.
poisoningsinaddictsinnorth-eastParisandsuburbs,1995–99.Addiction97, Rosen,C.S.,Kuhn,E.,Greenbaum,M.A.,Drescher,K.D.,2008.Substanceabuse-related
1295–1304. mortalityamongmiddle-agedmaleVApsychiatricpatients.PsychiatryServ.59,
Hickman,M.,Carnwath,Z.,Madden,P.,Farrell,M.,Rooney,C.,Ashcroft,R.,Judd,A., 290–296.
Stimson,G.,2003.Drug-relatedmortalityandfataloverdoserisk:pilotcohort Roshanaei-Moghaddam,B.,Katon,W.,2009.Prematuremortalityfromgeneralmed-
studyofheroinusersrecruitedfromspecialistdrugtreatmentsitesinLondon. icalillnessesamongpersonswithbipolardisorder:areview.PsychiatryServ.60,
J.UrbanHealth80,274–287. 147–156.
Hickman,M.,Carrivick,S.,Paterson,S.,Hunt,N.,Zador,D.,Cusick,L.,Henry,J.,2007. Saha,S.,Chant,D.,McGrath,J.,2007.Asystematicreviewofmortalityinschizophre-
Londonauditofdrug-relatedoverdosedeaths:characteristicsandtypology,and nia:isthedifferentialmortalitygapworseningovertime.Arch.Gen.Psychiatry
implicationsforpreventionandmonitoring.Addiction102,317–323. 64,1123–1131.
Hser,Y.I.,Stark,M.E.,Paredes,A.,Huang,D.,Anglin,M.D.,Rawson,R.,2006.A12- Sanchez-Carbonell,X.,Seus,L.,2000.Ten-yearsurvivalanalysisofacohortofheroin
yearfollow-upofatreatedcocaine-dependentsample.J.Subst.AbuseTreat.30, addictsinCatalonia:theEMETYSTproject.Addiction95,941–948.
219–226. Schifano,F.,2004.Abitterpill.Overviewofecstasy(MDMA,MDA)relatedfatalities.
Hulse,G.K.,English,D.R.,Milne,E.,Holman,C.D.,1999.Thequantificationofmor- Psychopharmacology(Berl.)173,242–248.
talityresultingfromtheregularuseofillicitopiates.Addiction94,221–229. Schifano, F., Corkery, J., 2008. Cocaine/crack cocaine consumption, treatment
Joe,G.W.,Lehman,W.,Simpson,D.D.,1982.Addictdeathratesduringafour-year demand,seizures,relatedoffences,prices,averagepuritylevelsanddeathsin
posttreatmentfollow-up.Am.J.PublicHealth72,703–709. theUK.J.Psychopharmacol.22,71–79.
Johnson,J.E.,Finney,J.W.,Moos,R.H.,2005.Predictorsof5-yearmortalityfollow- Shah, N.G., Lathrop, S.L., Reichard, R.R., Landen, M.G., 2008. Unintentional drug
inginpatient/residentialgrouptreatmentforsubstanceusedisorders.Addict. overdose death trends in New Mexico, USA, 1990–2005: combinations
Behav.30,1300–1316. of heroin, cocaine, prescription opioids and alcohol. Addiction 103, 126–
Knapp,W.P.,Soares,B.G.,Farrel,M.,Lima,M.S.,2007.Psychosocialinterventions 136.
forcocaineandpsychostimulantamphetaminesrelateddisorders.Cochrane Sherman,S.G.,Cheng,Y.,Kral,A.H.,2007.Prevalenceandcorrelatesofopiateover-
DatabaseSyst.Rev.,CD003023. doseamongyounginjectiondrugusersinalargeU.S.city.DrugAlcoholDepend.
Landheim,A.S.,Bakken,K.,Vaglum,P.,2006.Impactofcomorbidpsychiatricdisor- 88,182–187.
dersontheoutcomeofsubstanceabusers:asixyearprospectivefollow-upin Shields,L.B.,HunsakerIii,J.C.,Corey,T.S.,Ward,M.K.,Stewart,D.,2007.Methadone
twoNorwegiancounties.BMCPsychiatry6,44. toxicityfatalities:areviewofmedicalexaminercasesinalargemetropolitan
Laumon,B.,Gadegbeku,B.,Martin,J.L.,Biecheler,M.B.,2005.Cannabisintoxication area.J.ForensicSci.52,1389–1395.
andfatalroadcrashesinFrance:populationbasedcase–controlstudy.BMJ331, Sidney,S.,Beck,J.E.,Tekawa,I.S.,Quesenberry,C.P.,Friedman,G.D.,1997.Marijuana
1371. useandmortality.Am.J.PublicHealth87,585–590.
Macdonald,S.,Anglin-Bodrug,K.,Mann,R.E.,Erickson,P.,Hathaway,A.,Chipman, StataCorp,2007.StataStatisticalSoftware:Release10.StataCorpLP,CollegeStation,
M.,Rylett,M.,2003.Injuryriskassociatedwithcannabisandcocaineuse.Drug TX.
AlcoholDepend.72,99–115. StatisticsDenmark:www.statistikbanken.dk/statbank5a.(accessedon07.01.09).
Mesquita,F.,Kral,A.,Reingold,A.,Haddad,I.,Sanches,M.,Turienzo,G.,Piconez,D., Steentoft,A.,Teige,B.,Holmgren,P.,Vuori,E.,Kristinsson,J.,Hansen,A.C.,Ceder,G.,
Araujo,P.,Bueno,R.,2001.OverdosesamongcocaineusersinBrazil.Addiction Wethe,G.,Rollmann,D.,2006.FatalpoisoninginNordicdrugaddictsin2002.
96,1809–1813. ForensicSci.Int.160,148–156.
Mukamal, K.J., Maclure, M., Muller, J.E., Mittleman, M.A., 2008. An exploratory Swift,W.,Maher,L.,Sunjic,S.,1999.Transitionsbetweenroutesofheroinadmin-
prospectivestudyofmarijuanauseandmortalityfollowingacutemyocardial istration:astudyofCaucasianandIndochineseheroinusersinsouth-western
infarction.Am.HeartJ.155,465–470. Sydney,Australia.Addiction94,71–82.
Munk-Jørgensen,P.,Mortensen,P.,1997.TheDanishpsychiatriccentralregister. Torralba,L.,Brugal,M.T.,Villalbi,J.R.,Tortosa,M.T.,Toribio,A.,Valverde,J.L.,1996.
Dan.Med.Bull.44,82–84. Mortalityduetoacuteadversedrugreactions:opiatesandcocaineinBarcelona,
O’Dowd,A.,2008.DeathsfromdrugpoisoninginEnglishandWelshmenreachfive 1989–93.Addiction91,419–426.
yearpeak.BMJ337,a1521. Vlahov, D., Wang, C.L., Galai, N., Bareta, J., Mehta, S.H., Strathdee, S.A., Nelson,
Oppenheimer,E.,Tobutt,C.,Taylor,C.,Andrew,T.,1994.Deathandsurvivalina K.E.,2004.Mortalityriskamongnewonsetinjectiondrugusers.Addiction99,
cohortofheroinaddictsfromLondonclinics:a22-yearfollow-upstudy.Addic- 946–954.
tion89,1299–1308. Vlahov,D.,Wang,C.,Ompad,D.,Fuller,C.M.,Caceres,W.,Ouellet,L.,Kerndt,P.,Des
Pavarin,R.M.,2008.Cocaineconsumptionanddeathrisk:afollow-upstudyon347 Jarlais,D.C.,Garfein,R.S.,2008.Mortalityriskamongrecent-onsetinjectiondrug
cocaineaddictsinthemetropolitanareaofBologna.Ann.Ist.Super.Sanita44, usersinfiveU.S.cities.Subst.UseMisuse43,413–428.
91–98. Wahren,C.A.,Brandt,L.,Allebeck,P.,1997.Hasmortalityindrugaddictsincreased?
Pedersen,C.B.,Gøtzsche,H.,Møller,J.Ø.,Mortensen,P.B.,2006.TheDanishcivil AcomparisonbetweentwohospitalizedcohortsinStockholm.Int.J.Epidemiol.
registrationsystem.Dan.Med.Bull.53,441–449. 26,1219–1226.
Perucci,C.A.,Davoli,M.,Rapiti,E.,Abeni,D.D.,Forastiere,F.,1991.Mortalityofintra- Westover,A.N.,McBride,S.,Haley,R.W.,2007.Strokeinyoungadultswhoabuse
venousdrugusersinRome:acohortstudy.Am.J.PublicHealth81,1307–1310. amphetaminesorcocaine:apopulation-basedstudyofhospitalizedpatients.
Quaglio,G.,Talamini,G.,Lechi,A.,Venturini,L.,Lugoboni,F.,Mezzelani,P.,2001. Arch.Gen.Psychiatry64,495–502.
Studyof2708heroin-relateddeathsinnorth-easternItaly1985–98toestablish Wilcox,H.C.,Conner,K.R.,Caine,E.D.,2004.Associationofalcoholanddruguse
themaincausesofdeath.Addiction96,1127–1137. disordersandcompletedsuicide:anempiricalreviewofcohortstudies.Drug
Quan,V.M.,Vongchak,T.,Jittiwutikarn,J.,Kawichai,S.,Srirak,N.,Wiboonnatakul, AlcoholDepend.76(Suppl.),11–19.
K.,Razak,M.H.,Suriyanon,V.,Celentano,D.D.,2007.Predictorsofmortality WorldHealthOrganization,1971.ClassificationofDiseases:ExtendedDanish–Latin
amonginjectingandnon-injectingHIV-negativedrugusersinnorthernThai- VersionoftheWorldHealthOrganizationInternationalClassificationofDis-
land.Addiction102,441–446. eases.8thReview1965.DanishNationalBoardofHealth,Copenhagen,Denmark.
Ravndal,E.,Vaglum,P.,1998.Psychopathology,treatmentcompletionand5years World Health Organization, 1992. The ICD-10 Classification of Mental and
outcome:aprospectivestudyofdrugabusers.J.Subst.AbuseTreat.15,135–142. BehaviouralDisorders.WorldHealthOrganization,Geneva.
Regier, D.A., Farmer, M.E., Rae, D.S., Locke, B.Z., Keith, S.J., Judd, L.L., Goodwin, Zivin,K.,Kim,H.M.,McCarthy,J.F.,Austin,K.L.,Hoggatt,K.J.,Walters,H.,Valen-
F.K., 1990. Comorbidity of mental disorders with alcohol and other drug stein,M.,2007.Suicidemortalityamongindividualsreceivingtreatmentfor
abuse.Resultsfromtheepidemiologiccatchmentarea(ECA)study.JAMA264, depressionintheVeteransAffairshealthsystem:associationswithpatientand
2511–2518. treatmentsettingcharacteristics.Am.J.PublicHealth97,2193–2198.
